Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.

Authors

null

Philipp K. Haber

Icahn School of Medicine at Mount Sinai, New York, NY

Philipp K. Haber , Miguel Torres-Martin , Jean-Francois Dufour , Chris Verslype , Jens Marquardt , Peter R. Galle , Arndt Vogel , Tim Meyer , Ismail Labgaa , Lewis R. Roberts , Beatriz Minguez , Vincenzo Mazzaferro , Fabian Finkelmeier , Tobias Müller , Moritz Schmelzle , Richard S. Finn , Swan Thung , Augusto Villanueva , Daniela Sia , Josep M Llovet

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4100)

DOI

10.1200/JCO.2021.39.15_suppl.4100

Abstract #

4100

Poster Bd #

Online Only

Abstract Disclosures